Skip to main content
. 2017 Sep 5;17:620. doi: 10.1186/s12885-017-3631-8

Table 3.

Clinical and pathological characteristics of the CHEK2 c.1100delC carriers

Age range at diagnosis T N M Histology ER PR Grade Her2 Family history of breast cancer Family history of prostate cancer Family history of ovarian cancer BRCA1/2 mutation
65–70 1 1 0 Ductal Positive Positive 3 n.a. n.a. n.a. n.a. Negative
45–50 1 0 0 Ductal Positive Negative 2 n.a. Negative Negative Negative Negative
40–45 1 1 0 Ductal Positive Negative 3 Negative Positive n.a. n.a. Negative
75–80 1 0 0 Ductal Positive Positive 2 Positive Negative n.a. n.a. Negative